Task: Answer the multiple-choice question.
Question: Which compound exhibits a -2.485% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) Cc1c(Cl)c(-c2n[nH]c(=S)n2-c2ccc(F)cc2)nn1C
b.) CN(C)P(=NC(=O)COc1ccc(Cl)cc1Cl)(N(C)C)N(C)C
Answer: b. CN(C)P(=NC(=O)COc1ccc(Cl)cc1Cl)(N(C)C)N(C)C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CN(C)P(=NC(=O)COc1ccc(Cl)cc1Cl)(N(C)C)N(C)C
CN(C)P(=NC(=O)COc1ccc(Cl)cc1Cl)(N(C)C)N(C)C
2-(2,4-dichlorophenoxy)-N-[tris(dimethylamino)-λ5-phosphanylidene]acetamide